celltissuescience-blog

[celltissuescience-blog]

New blood test developed for early diagnosis of ovarian cancer

Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer – a disease which kills over 1000 Australian women and 150,000 globally each year.

The new blood test has the potential to dramatically improve early detection of the disease, although it will require further testing before it is available for clinicians.

A research team from the University of Adelaide and Griffith University have been studying the interactions between the toxin and an abnormal glycan (sugar) expressed on the surface of human cancer cells and released into the blood.

The team has now engineered a harmless portion of the toxin to enhance its specificity for the cancer glycan and used this to detect it in blood samples from women with ovarian cancer.

A paper published this month in Biochemical and Biophysical Research Communications has shown that the new test detected significant levels of the cancer glycan in blood samples from over 90% of women with stage 1 ovarian cancer and in 100% of samples from later stages of the disease, but not in any of the samples from healthy controls.

“Ovarian cancer is notoriously difficult to detect in its early stages, when there are more options for treatment and survival rates are better. Our new test is therefore a potential game changer,” says Professor James Paton, Director of the University of Adelaide’s Research Centre for Infectious Diseases.

Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, said: “Detection of this tumor marker may also play a role in a simple liquid biopsy to monitor disease stage and treatment.”

The team is currently seeking scientific and commercial partners to further test the technology with larger numbers of patient samples and to adapt it for mass screening.

We welcome researchers from different part of the to submit abstract on their latest research at our upcoming conference Cell Tissue Science 2019 which is mainly focuses on the complications the consequences of Stem Cell, Regenerative Medicine, Stem Cell Therapy, Cancer Cell Biology , Technical Advancements in cancer treatment and many more.We welcome you to the our upcoming conference “ 12th World Congress on Cell & Tissue Science” .

You can submit your abstract on Session or Track : 8.Advancement in Cancer Treatment

[celltissuescience-blog]

Session of Cell Tissue Science

Cell Tissue Science 2019

We invite speaker to the conference 12th World Congress on Cell & Tissue Science scheduled on March 11-12,2019 in Singapore to present their latest research and innovation from the field of Cell Biology.

Track 1: Cell Biology *************************************************************************************** Cell Biology is the discipline that studies the molecular structure, function and behavior of cells in the complexity of tissues and organs in the human body in order to understand mechanisms of disease. Differences in the Cellular structure and the approach of internal mechanisms form the basis of the first major divisions of life. This is done both on a microscopic and molecular level as it encompasses eukaryotic cells and prokaryotic cells. Knowing the components of cells and their functionalist is the fundamental to all biological sciences. It is also very important for the researchers in bio-medical fields such as cancer, and other diseases. Research in cell biology is closely related to genetics, biochemistry, molecular biology, immunology, and developmental biology. Link: https://tissuesciencecongress.conferenceseries.com/events-list/cell-biology

[celltissuescience-blog]

New lung cancer guides aim to drive better outcomes and care

wo new, national guides that aim to drive better outcomes and care for all people affected by lung cancer were released by Cancer Australia. Lung cancer is the leading cause of death from cancer in Australia with an estimated 25 people dying every day from the disease in 2018.

All lung cancer patients, regardless of where they live, should have the benefit of the best care and have the best possible experience. These resources distill the essential elements of what that care should be and how to deliver it,”

Dr Helen Zorbas, CEO Cancer Australia

Separate resources have been designed for health professionals and consumers, which share the goal of achieving optimal patient outcomes.

Delivering best practice lung cancer care for health professionals contains evidence-based, best practice information, strategies, tools and resources to support clinicians in providing consistent, high quality care for people affected by lung cancer.

I encourage all those involved in lung cancer care in Australia to implement and use these guides as part of a national coordinated effort to improve lung cancer outcomes.”

Dr Zorbas

The resources build on the Lung Cancer Framework: Principles for Best Practice Lung Cancer Care in Australia, which support the uptake and use of the Principles for best practice care: patient-centred care; timely access to evidence-based pathways of care; multi-disciplinary care; coordination, communication and continuity of care; and data-driven improvements in lung cancer care.

To empower patients to actively participate in their own care, Getting the best advice and care, a guide for those affected by lung cancer provides information about what the principles will mean to them and what they can do better engage with health care professionals and make informed evidence-based decisions.

Dr Zorbas said the guides articulate the clear benefits to patients of implementing each of the principles –from improving survival to reducing anxiety and depression.

Releasing these resources during Lung Cancer Awareness Month serves as a timely reminder that anyone experiencing symptoms such as a persistent cough lasting 3 weeks or more, coughing up blood, a chest infection that won’t go away, or a changed cough should visit a doctor.

Although lung cancer mostly occurs in people over 60 years, it can affect people of any age, regardless of whether they smoke. It is estimated that in 2018, 12,741 people will be diagnosed with lung cancer in Australia.

The development of Lung Cancer Framework: Principles for Best Practice Lung Cancer Care in Australia and these new resources by Cancer Australia was guided by systematic and exacting reviews of the highest quality evidence and incorporates learnings and experiences from people affected by lung cancer. A national demonstration project was undertaken, along with consultation with health professionals and consumers, supported by Cancer Australia’s Lung Cancer Advisory Group.

We welcome researchers from different part of the to submit abstract on their latest research at our upcoming conference Cell Tissue Science 2019 which is mainly focuses on the complications the consequences of Stem Cell, Regenerative Medicine, Stem Cell Therapy, Cancer Cell Biology , Technical Advancements in cancer treatment and many more.We welcome you to the our upcoming conference “ 12th World Congress on Cell & Tissue Science” .

You can submit your abstract on Session or Track : 8.Advancement in Cancer Treatment

[celltissuescience-blog]

Conference Series LLC LTD extends warm invitation to all the participants across the globe to attend “12th World Congress on Cell and Tissue Science”(Celltissue Science 2019) which is going to be held during March 11-12, 2019  in Singapore which includes prompt Keynote Presentations, Workshops, Oral talks, Poster presentations and Exhibitions working under the fields Cell Therapy, Gene Therapy, Anti-Aging, Cell Biology, Stem Cells, Organ Regeneration, Tissue Engineering and Regenerative Medicine to discuss materials-related strategies and new innovation for disease remediation and prevention.

Cell Tissue Science 2019 aims to strengthen the collaboration and to provide a forum for academicians, professionals and researchers to discuss and exchange their research ideas, innovation ideas and experience in aspects of intelligences and advance technologies as well as identifying the emerging topics which will define the future directions to achieve sustainable development. You are cordially invited to submit your recent research work to Cell Tissue Science 2019.

Conference Highlights

·         Cell Biology

·         Cellular and Gene Therapy

·         Cell and Organ Engineering

·         Cell and Organ Regeneration

·         Tissue Science and Engineering

·         Tissue Repair and Regeneration

·         Cancer Cell Biology

·         Advancement in Cancer Treatments

·         Stem Cells and its Applications

·         Biomaterial and Bioengineering

·         Biobanking

·         Epigenetics and Epigenome

·         Artificial Organs

·         Tissue Culture and Preservation

·         Regenerative Medicine

·         Anti-Aging Medicine

·         Precision Medicine

·         Translational Medicine

·         Vitrification

·   ��     Ethical Issues and Marketing Status Around the Globe

Conference Website: https://tissuesciencecongress.conferenceseries.com

Link for Conference Brochure Download: https://tissuesciencecongress.conferenceseries.com/conference-brochure.php

Link for Abstract Submission: https://tissuesciencecongress.conferenceseries.com/abstract-submission.php

Link for registration:

https://tissuesciencecongress.conferenceseries.com/registration.php